Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen.
Saved in:
| Title: | Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen. |
|---|---|
| Authors: | Johnson K; William Carey University School of Pharmacy, Departments of Pharmaceutical Sciences and Pharmacy Practice, Biloxi, MS, United States., Weldon AJ; William Carey University School of Pharmacy, Department of Pharmaceutical Sciences, Biloxi, MS, United States., Burmeister MA; William Carey University School of Pharmacy, Department of Pharmaceutical Sciences, Biloxi, MS, United States. |
| Source: | Frontiers in psychiatry [Front Psychiatry] 2024 Apr 23; Vol. 15, pp. 1386263. Date of Electronic Publication: 2024 Apr 23 (Print Publication: 2024). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1664-0640 |
|---|---|
| DOI: | 10.3389/fpsyt.2024.1386263 |
